Cerivastatin inhibits fetal calf serum-induced DNA synthesis in cultured rat mesangial cells

Nephrology

Volumn 7, Issue 2, 2002, Pages 83-86

  He, Jin Song ^a   Horikoshi, Satoshi ^a   Funabiki, Kazuhiko ^a   Shirato, Isao ^a   Tomino, Yasuhiko ^a  

^a JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Cerivastatin; DNA synthesis; Mesangial cell

Indexed keywords

BROXURIDINE; CERIVASTATIN; MEVALONIC ACID;

ANIMAL CELL; ARTICLE; CELL CULTURE; CELL STIMULATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DNA REPLICATION; DNA SYNTHESIS INHIBITION; DRUG EFFECT; FETAL CALF SERUM; IC 50; INCUBATION TIME; MALE; MESANGIUM CELL; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0036046476     PISSN: 13205358     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1797.2002.00077.x     Document Type: Article

References (18)

1. Cytokines, growth factors and renal injury: Where do we go now?
2. Cell cycle: Routine role for Ras
3. Simvastatin inhibits PDGF-induced DNA synthesis in human glomerular mesangial cells
4. Lovastatin inhibits proliferation of rat mesangial cells
5. Importance of geranylgeranyl pyrophosphate for mesangial cell DNA synthesis
6. Clinical pharmacokinetics of cerivastain
7. Inhibition of MAP kinase by prostaglandin E2 and forskolin in rat renal mesangial cells
8. Expression of cystein proteinases and their inhibitor, cystatin β, in cultured rat mesangial cells
9. Inhibition of Ras and related G-proteins as a therapeutic strategy for blocking malignant glioma growth
10. An enzyme-linked immunosorbent assay for bromodeoxyuridine incorporation using fixed microcultures
11. Inhibition of proliferation of human smooth muscle cells by various HMG-CoA reductase inhibitors; comparison with other human cell types
12. Relation of cholesterol and mevalonic acid to the cell cycle in smooth muscle and Swiss 3T3 cells stimulated to divide by platelet-derived growth factor
13. The MAPK signaling cascade
14. The mitogen-activated protein kinase signal transduction pathway
15. Effect of inhibition of cholesterol synthetic pathway on the activation of Ras and MAP kinase in mesangial cells
16. Isoprenoid addition to Ras protein is the critical modification for its membrane association and transforming activity
17. p21 Ras is modified by a farnesyl isoprenoid
18. Effects of lipid-lowering agents in the Dahl-salt-sensitive rat